Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

33.67
-0.3800-1.12%
Post-market: 33.50-0.1700-0.50%19:59 EDT
Volume:10.49M
Turnover:364.28M
Market Cap:2.41B
PE:-5.71
High:37.14
Open:37.14
Low:32.73
Close:34.05
52wk High:56.05
52wk Low:23.05
Shares:71.71M
Float Shares:52.39M
Volume Ratio:5.29
T/O Rate:20.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.92
PE(LYR):-7.22

Loading ...

Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2025

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]